One To Watch

Travere Therapeutics

A pharmaceutical company, based in USA, focused on developing rare diseases and hepatological therapeutics targeting significant areas of unmet medical need.

Company Overview

Travere Therapeutics is a pharmaceutical company, based in USA, focused on developing therapeutics for rare diseases and hepatological. The company has active programmes in clinical development. Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to pe...

Headquarters and Global Presence

Travere Therapeutics is headquartered in USA. The United States remains the world's largest pharmaceutical market, providing access to a deep talent pool, leading academic medical centres, and the FDA regulatory pathway.

Founding and History

Travere Therapeutics was established to develop therapeutics within its core disease focus areas. Travere Therapeutics has received industry recognition for its work. Company History Travere Therapeutics, originally founded as Retrophin Inc

Therapy Areas and Focus

Travere Therapeutics' therapeutic portfolio is centered on rare diseases, hepatological, and metabolic and endocrine diseases, an area with significant unmet medical need and active industry investment.

Technology Platforms and Modalities

Travere Therapeutics employs a proprietary technology platform to support its therapeutic development programmes. The company's scientific approach is designed to address its target diseases through differentiated mechanisms of action. The choice of therapeutic modality influences target accessibility, manufacturing complexity, and competitive positioning.

Key Pipeline and Programs

Travere Therapeutics maintains an active pipeline of therapeutic programmes across its focus areas. The company has programmes in clinical development, with ongoing trials evaluating safety and efficacy. Pipeline progress and clinical data readouts represent key catalysts for Travere Therapeutics in the near to medium term.

Key Personnel

Travere Therapeutics is led by an experienced management team with expertise in drug development, regulatory affairs, and pharmaceutical operations. Travere Therapeutics employs 493 employees

Strategic Partnerships

Travere Therapeutics has established strategic partnerships with NURTuRE, reflecting the company's collaborative approach to development. The company has received industry recognition for its work.

FAQ Section

Travere Therapeutics' key strategic challenge is advancing its pipeline through clinical development while managing capital requirements and demonstrating proof of concept. Success with the lead programme will be critical for attracting further investment and partnership interest.

Rare diseases represents a significant area of unmet medical need, with substantial industry investment and clinical activity. Travere Therapeutics' focus on this space positions it to address patient populations with limited treatment options and high demand for new therapies.

Travere Therapeutics' approach is differentiated by its proprietary technology platform and therapeutic strategy, which aim to offer advantages over existing treatment paradigms. The company's scientific foundation provides a basis for developing programmes across its target disease areas.

Travere Therapeutics' lead programme represents the company's most advanced asset and near-term value driver. Its progression through development milestones will be closely watched by investors and potential partners as validation of the technology.

Travere Therapeutics' pipeline is centered on rare diseases, hepatological, metabolic and endocrine diseases, renal, and oncology, with programmes targeting specific indications within this space. The company's therapeutic focus reflects a strategic commitment to disease areas with significant unmet need and commercial opportunity.

Travere Therapeutics has programmes in Phase I clinical trials, the earliest stage of human testing focused on safety and dosing.

Key watchpoints for Travere Therapeutics include: